Terms: = Liver cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Staging
9 results:
1. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
[TBL] [Abstract] [Full Text] [Related]
2. Changes in the Role and Mode of liver Resection for Hepatocellular Carcinoma Over 20 Years: A Single-Center Analysis.
Eguchi S; Hidaka M; Kugiyama T; Soyama A; Hara T; Nagakawa K; Adachi T; Tanaka T; Yoshimoto T; Hamada T; Matsushima H; Ito S; Kanetaka K
World J Surg; 2021 Apr; 45(4):1152-1158. PubMed ID: 33491142
[TBL] [Abstract] [Full Text] [Related]
3. Development of machine learning-based clinical decision support system for hepatocellular carcinoma.
Choi GH; Yun J; Choi J; Lee D; Shim JH; Lee HC; Chung YH; Lee YS; Park B; Kim N; Kim KM
Sci Rep; 2020 Sep; 10(1):14855. PubMed ID: 32908183
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Kim CG; Lee HW; Choi HJ; Lee JI; Lee HW; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim HS; Kim KH; Choi SJ; Kim Y; Lee KS; Kim GM; Kim MD; Won JY; Lee DY; Kim BK
Cancer Med; 2019 Sep; 8(11):5023-5032. PubMed ID: 31290618
[TBL] [Abstract] [Full Text] [Related]
5. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
[TBL] [Abstract] [Full Text] [Related]
7. Health insurance status affects staging and influences treatment strategies in patients with hepatocellular carcinoma.
Zaydfudim V; Whiteside MA; Griffin MR; Feurer ID; Wright JK; Pinson CW
Ann Surg Oncol; 2010 Dec; 17(12):3104-11. PubMed ID: 20585872
[TBL] [Abstract] [Full Text] [Related]
8. The cancer of the liver Italian Program (CLIP) score: validation of a new prognostic system for hepatocellular carcinoma.
Takanishi DM; Severino R; Wong LL
Hawaii Med J; 2007 Aug; 66(8):209-12. PubMed ID: 17941373
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic liver cancer staging classification, and Tokyo score.
Chung H; Kudo M; Takahashi S; Hagiwara S; Sakaguchi Y; Inoue T; Minami Y; Ueshima K; Fukunaga T; Matsunaga T
J Gastroenterol Hepatol; 2008 Mar; 23(3):445-52. PubMed ID: 17683486
[TBL] [Abstract] [Full Text] [Related]
